Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	150	151	97	71	70	5
Market Cap Growth	100.05%	54.55%	37.70%	0.89%	1190.39%	-57.33%
Enterprise Value	112	113	59	39	38	-4
PE Ratio	-	-6.76	-3.36	-3.53	-5.13	-0.71
PS Ratio	5.53	5.98	38.19	288.92	226.06	5.41
PB Ratio	8.14	6.66	8.27	2.26	2.49	0.80
P/FCF Ratio	-6.40	-5.45	62.58	-3.93	-6.61	-0.80
P/OCF Ratio	-6.86	-5.88	19.82	-4.21	-6.98	-0.80
EV/Sales Ratio	4.14	4.50	22.96	158.20	121.80	-4.43
EV/EBITDA Ratio	-7.57	-5.34	-2.06	-1.96	-2.80	0.60
EV/EBIT Ratio	-7.21	-5.08	-2.02	-1.93	-2.77	0.58
EV/FCF Ratio	-5.26	-4.10	37.62	-2.15	-3.56	0.65
Debt / Equity Ratio	0.11	0.10	0.22	0.09	0.01	-
Debt / EBITDA Ratio	-0.09	-0.11	-0.09	-0.15	-0.02	-
Debt / FCF Ratio	-0.06	-0.08	1.64	-0.16	-0.03	-
Quick Ratio	1.53	1.59	1.78	8.53	10.99	11.11
Current Ratio	1.57	1.63	1.82	8.82	11.33	11.74
Asset Turnover	0.57	0.51	0.05	0.01	0.01	0.12
Return on Equity (ROE)	-231.70%	-299.70%	-164.50%	-58.10%	-54.70%	-185.10%
Return on Assets (ROA)	-50.80%	-45.50%	-51.10%	-47.70%	-44.70%	-87.50%
Return on Capital (ROIC)	-127.88%	-96.94%	-207.01%	-61.16%	-48.00%	-113.08%
Earnings Yield	-16.21%	-14.80%	-29.78%	-28.30%	-19.47%	-140.60%
FCF Yield	-22.23%	-18.36%	1.60%	-25.45%	-15.12%	-125.51%
Buyback Yield / Dilution	-24.19%	-9.06%	-6.34%	-48.28%	-319.55%	-26.19%
Total Shareholder Return	-24.19%	-9.06%	-6.34%	-48.28%	-319.55%	-26.19%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).